Please assess the completion status of the following clinical trial:

Trial Title: Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Good general health~* Written informed consent provided by or for the subject~* Aboriginal ethnicity (First Nations, Metis or Inuit)~* Adults 20-59 years of age~* Children 6-35 months of age~Exclusion Criteria:~* Allergies to eggs, thimerosal or gentamicin sulphate~* Life-threatening reaction to previous Flu vaccine~* Bleeding disorder~* Pregnancy~* Receipt of blood or blood products in past 3 months~* Compromised immune system~* Chronic illness~* Previous lab-confirmed H1N1/2009 infection

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 59 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: OTHER): Adults: One doses of H1N12009 vaccine
- 2 (Type: OTHER): Children: Two doses of H1N12009 vaccine given 3 weeks apart

Based on this trial design, predict the completion outcome and termination type (if applicable).